As many of you know, who follow my post, CBD is a cannabinoid neurotransmitter in the same group as THC and dozens other more minor cannabinoids – at least at this point in time. There is little doubt in my mind that many other cannabinoids will find extremely useful places in the anti-tumor and anti-biotic worlds. Stay tune for CBG and others.
In the meantime, let’s expound a bit on CBD. Research sponsored by the NIH and run at UCSF, has shown some very impressive anti-tumor effects of CBD at fairly “low” doses. I quote “low”, because we are still learning what low means and of course how does the dosing translate to humans. Much of the data is still unpublished but suffice it to say, I was stunned. Truly stunned, particularly by the Human Breast Cancer treatment with CBD and how it works. (more in another blog).
Cancer aside, CBD, is a non-psychoactive neurotransmitter that has purported wondrous effects on pain and anxiety. So, a tincture richer in CBD and balanced to varying extents with differing concentrations of THC will lead us to blends of many tinctures more and more specific to different patient problems; also, with or without psycho activity!
So, imagine, a tincture counter where patients could test single doses of varying tinctures under the care of their care-giver and reporting the various effects of the various tinctures. This would not be a true “trial”, but we will gather information. Once a supply of this tincture is available, it will in part be made available through http://projectCBD.com. Let me be very clear. Project CBD can only let you know where these products become available.
As this and other products become available, even for just testing, http://projectCBD.com will be a great resource for all of you.